STOCK TITAN

Seagen to Report Third Quarter 2023 Financial Results on November 1, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Seagen Inc. to report Q3 2023 financial results
Positive
  • Seagen Inc. will report its third quarter 2023 financial results on November 1, 2023.
Negative
  • None.

BOTHELL, Wash.--(BUSINESS WIRE)-- Seagen Inc. (Nasdaq: SGEN) announced today that it will report third quarter 2023 financial results on Wednesday, November 1, 2023.

Given the previously announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call.

About Seagen

Founded 25 years ago, Seagen Inc. is a global biotechnology company that discovers, develops, manufactures and commercializes targeted cancer therapeutics, with antibody-drug conjugates (ADCs) at our core. Our colleagues work together with urgency to improve and extend the lives of people living with cancer. An ADC technology trailblazer, approximately one-third of FDA-approved and marketed ADCs use Seagen technology. Seagen is headquartered in Bothell, Washington and has locations in California, Canada, Switzerland and across Europe. For additional information, visit www.seagen.com and follow us on Twitter and LinkedIn.

For Investors

Douglas Maffei, Ph.D.

Vice President, Investor Relations

(425) 527-4881

dmaffei@seagen.com

For Media

David Caouette

Vice President, Corporate Communications

(310) 430-3476

dcaouette@seagen.com

Source: Seagen Inc.

FAQ

When will Seagen Inc. report its Q3 2023 financial results?

Seagen Inc. will report its Q3 2023 financial results on Wednesday, November 1, 2023.

Will Seagen Inc. host a conference call for its Q3 2023 financial results?

No, Seagen Inc. will not be hosting a conference call due to the previously announced agreement to be acquired by Pfizer Inc.

Seagen Inc.

NASDAQ:SGEN

SGEN Rankings

SGEN Latest News

SGEN Stock Data

43.15B
187.13M
0.81%
88.83%
5.08%
Biotechnology
Healthcare
Link
United States
Bothell